Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Hookipa Pharma Inc (HOOK)

Hookipa Pharma Inc (HOOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
HOOKIPA Pharma Inc. (HOOK) Reports Q1 Loss, Lags Revenue Estimates Zacks - Thu May 11, 2023

HOOKIPA Pharma Inc. (HOOK) delivered earnings and revenue surprises of -12.50% and 15.31%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

HOOK : 0.8803 (-5.36%)
CELU : 3.08 (-6.38%)
Mirati (MRTX) Reports Q1 Loss, Tops Revenue Estimates Zacks - Tue May 9, 2023

Mirati (MRTX) delivered earnings and revenue surprises of 8.36% and 41.08%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

MRTX : 58.70 (-0.17%)
HOOK : 0.8803 (-5.36%)
HOOKIPA Pharma Inc. (HOOK) Reports Q4 Loss, Tops Revenue Estimates Zacks - Wed Mar 15, 2023

HOOKIPA Pharma Inc. (HOOK) delivered earnings and revenue surprises of 5.56% and 41.25%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

HOOK : 0.8803 (-5.36%)
ADMA : 6.91 (+1.47%)
Avid Bioservices (CDMO) Q3 Earnings and Revenues Top Estimates Zacks - Mon Mar 13, 2023

Avid Bioservices (CDMO) delivered earnings and revenue surprises of 275% and 5.61%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?

CDMO : 8.42 (+2.06%)
HOOK : 0.8803 (-5.36%)
Intercept Pharmaceuticals (ICPT) Reports Q4 Loss, Tops Revenue Estimates Zacks - Thu Mar 2, 2023

Intercept (ICPT) delivered earnings and revenue surprises of 20.75% and 0.42%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

ICPT : 19.00 (+0.21%)
HOOK : 0.8803 (-5.36%)
HOOKIPA Pharma Inc. (HOOK) Reports Q3 Loss, Misses Revenue Estimates Zacks - Mon Nov 14, 2022

HOOKIPA Pharma Inc. (HOOK) delivered earnings and revenue surprises of -4.17% and 31.49%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

HOOK : 0.8803 (-5.36%)
CDMO : 8.42 (+2.06%)
Werewolf Therapeutics, Inc. (HOWL) Reports Q3 Loss, Misses Revenue Estimates Zacks - Thu Nov 10, 2022

Werewolf Therapeutics, Inc. (HOWL) delivered earnings and revenue surprises of 33.33% and 18.53%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...

HOWL : 5.98 (-1.48%)
HOOK : 0.8803 (-5.36%)
AVEO Pharmaceuticals (AVEO) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release Zacks - Mon Nov 7, 2022

AVEO (AVEO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AVEO : 15.00 (unch)
HOOK : 0.8803 (-5.36%)
HOOKIPA Pharma Inc. (HOOK) Expected to Beat Earnings Estimates: Should You Buy? Zacks - Wed Nov 2, 2022

HOOKIPA Pharma Inc. (HOOK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HOOK : 0.8803 (-5.36%)
RVNC : 4.10 (+3.80%)
GSK Gears Up to Report Q3 Earnings: What's in the Cards? Zacks - Mon Oct 31, 2022

Sales of GSK's vaccine segment, especially meningitis and influenza vaccines, are likely to have been an important contributor to third-quarter 2022 sales.

GSK : 43.45 (-0.11%)
ANGN : 10.0000 (+2.04%)
HOOK : 0.8803 (-5.36%)
VIR : 10.22 (-1.64%)

Barchart Exclusives

Stock Index Futures Muted Ahead of More Fed Speak, Disney Earnings on Tap Barchart - 24 minutes ago
June S&P 500 E-Mini futures (ESM24) are up +0.09%, and June Nasdaq 100 E-Mini futures (NQM24) are down -0.02% this morning after three major U.S. benchmark indices ended the regular session higher as recent U.S. jobs data and remarks from Federal Reserve officials buoyed rate-cut hopes while investors awaited further signals on interest rates from the Fed and a new batch of earnings reports. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot